Godfrey H - Search Results

1

Neurologic adverse events associated with BRAF and MEK inhibitor therapy in patients with malignant melanoma: a disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System.

Leibovit-Reiben Z, Godfrey H, Jedlowski P, Thiede R. Leibovit-Reiben Z, et al. Among authors: godfrey h. Melanoma Res. 2024 Dec 6. doi: 10.1097/CMR.0000000000001015. Online ahead of print. Melanoma Res. 2024. PMID: 39656586

2

Erythema multiforme associated with the immune checkpoint inhibitors: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System.

Godfrey H, Leibovit-Reiben Z, Jedlowski P, Thiede R. Godfrey H, et al. J Am Acad Dermatol. 2024 Dec;91(6):1233-1234. doi: 10.1016/j.jaad.2024.08.021. Epub 2024 Aug 19. J Am Acad Dermatol. 2024. PMID: 39168310 No abstract available.

3

More than just dermatitis: The multifaceted nature of chronic itch through the historical perspective of Napoleon Bonaparte.

Leibovit-Reiben Z, Godfrey H, Stanley A, Thiede R. Leibovit-Reiben Z, et al. Among authors: godfrey h. Clin Dermatol. 2024 Nov-Dec;42(6):709-714. doi: 10.1016/j.clindermatol.2024.06.025. Epub 2024 Jun 28. Clin Dermatol. 2024. PMID: 38944246

4

Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023.

Godfrey H, Leibovit-Reiben Z, Jedlowski P, Thiede R. Godfrey H, et al. J Eur Acad Dermatol Venereol. 2025 Feb;39(2):e153-e154. doi: 10.1111/jdv.20197. Epub 2024 Jun 24. J Eur Acad Dermatol Venereol. 2025. PMID: 38925559 No abstract available.

5

Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System.

Godfrey H, Jedlowski P, Thiede R. Godfrey H, et al. Australas J Dermatol. 2024 May;65(3):243-253. doi: 10.1111/ajd.14262. Epub 2024 Apr 4. Australas J Dermatol. 2024. PMID: 38572842

6

Description of the fasted serum metabolomic signature of lean and obese cats at maintenance and of obese cats under energy restriction.

Grant CE, Godfrey H, Tal M, Bakovic M, Shoveller AK, Blois SL, Hesta M, Verbrugghe A. Grant CE, et al. Among authors: godfrey h. PLoS One. 2024 Mar 15;19(3):e0299375. doi: 10.1371/journal.pone.0299375. eCollection 2024. PLoS One. 2024. PMID: 38489282 Free PMC article.

7

Identifying the target population and preventive strategies to combat feline obesity.

Godfrey H, Morrow S, Abood SK, Verbrugghe A. Godfrey H, et al. J Feline Med Surg. 2024 Feb;26(2):1098612X241228042. doi: 10.1177/1098612X241228042. J Feline Med Surg. 2024. PMID: 38415669 Free PMC article. Review.

8

Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.

Godfrey H, Jedlowski P, Thiede R. Godfrey H, et al. J Cutan Med Surg. 2024 Jan-Feb;28(1):51-58. doi: 10.1177/12034754231220931. Epub 2024 Jan 8. J Cutan Med Surg. 2024. PMID: 38189282

9

Microbiology, Public Health, and the Murals of Diego Rivera.

Cabello FC, Godfrey HP. Cabello FC, et al. Among authors: godfrey hp. Clin Infect Dis. 2024 Jun 14;78(6):1662-1668. doi: 10.1093/cid/ciad715. Clin Infect Dis. 2024. PMID: 37991416

10

Ontogenetic morphometry of the brown smoothhound shark Mustelus henlei with implications for ecology and evolution.

Gayford JH, Godfrey H, Whitehead DA. Gayford JH, et al. Among authors: godfrey h. J Morphol. 2023 Aug;284(8):e21608. doi: 10.1002/jmor.21608. J Morphol. 2023. PMID: 37458085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters